Ten firms win second joint Nordic medicine tender

Procurement organizations from Denmark, Norway and Iceland have come together to offer agreements with 10 undisclosed companies in the second joint Nordic tendering procedure for medicines.

A total of 12 companies competed in the second joint Nordic tender regarding 13 drugs. Ten winners now have contracts spanning April 1, 2022, to March 31, 2024, with the option to extend.

The Danish regions’ procurement organization, Amgros, alongside corresponding organizations in Norway and Iceland, have named the winners of the second joint Nordic tendering procedure for medicines. The first round took place in April 2019, in which only Denmark and Norway participated.

A total of 12 companies made bids this time, Amgros tells MedWatch.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Rumored GN purchase unlikely but not impossible, say analysts

A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.

New CFO wants to shake things up at WSA

A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.

Further reading

Latest news

See all jobs